glp 2 tirz 10 mg
Base Peps

CBS Product #TZ10G2

$54.00

Tirzepatide is a dual incretin receptor agonist that simultaneously activates the GLP-1 (Glucagon-Like Peptide-1)and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors.
This dual mechanism makes it a next-generation peptide in metabolic and weight regulation research, combining the glucose-lowering effects of GLP-1 agonists with the metabolic advantages of GIP stimulation.

49 in stock (can be backordered)

10-vial kit 20% OFF
$540.00 $432.00 per kit

Need more? Buy 2+ kits at 30% off on the wholesale shop. See wholesale →

All products are sold for laboratory research use only. Not for human or animal consumption. You must be 18+ to purchase. By ordering you agree to our Terms.
Category:
  • ≥99% HPLC verified Independent third-party testing
  • COA included Certificate of analysis on every batch
  • Ships from the US 2–3 day express delivery

Description

GLP-2 Tirzepatide 10 MG

GLP2-T is a dual-action GIP/GLP-1 receptor agonist investigated for its enhanced metabolic effects compared to selective GLP-1 agonists. By activating both the glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors simultaneously, it provides complementary pathways for metabolic regulation.

Molecular Profile:

  • Classification: Dual GIP/GLP-1 Receptor Agonist
  • Targets: GIPR + GLP-1R
  • Mechanism: Dual incretin receptor activation

Research Applications:

  • Dual incretin pathway synergy studies
  • Enhanced glycemic control versus mono-agonist research
  • Body weight and adipose tissue regulation
  • Lipid metabolism and hepatic steatosis models
  • Beta-cell function preservation studies
  • Cardiovascular risk factor analysis

Quality Standards:

  • Purity: ≥99% verified by HPLC
  • Third-party tested with COA included

FOR RESEARCH USE ONLY. Not for human consumption.

Additional information

Vial Pricing

10-vial kit pricing, Per vial pricing

You may also like

More HPLC-verified peptides from the catalog